|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.72 USD | +1.75% |
|
-1.87% | 0.00% |
| Apr. 15 | Leerink Partners Starts LENZ Therapeutics With Outperform Rating, $32 Price Target | MT |
| Apr. 15 | William Blair Starts LENZ Therapeutics With Outperform Rating | MT |
LENZ Therapeutics, Inc Added to NASDAQ Composite Index.
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 401M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
LENZ THERAPEUTICS, INC. 
